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Abstract:  Tobacco use among American Indians has a long and complicated history 
ranging from its utilization in spiritual ceremonies to its importance as an economic factor 
for survival. Despite this cultural tradition and long history, there are few studies of the 
health effects of tobacco in this population. The Strong Heart Study is a prospective 
observational study of cardiovascular disease (CVD) in 13 American Indian tribes in 
Arizona, Oklahoma, and North and South Dakota with 4,549 participants. Baseline 
examinations were followed by two examinations at regular intervals and 16 years of 
morbidity and mortality follow-up. Hazard ratios (HRs) for non-fatal CVD for current 
smokers vs. non-smokers after adjusting for other risk factors were significant in women 
(HR = 1.94, 95% CI 1.54 to 2.45) and men (HR = 1.59, 95% CI 1.16 to 2.18). Hazard 
ratios for fatal CVD for current smokers vs. non-smokers after adjusting for other risk 
factors were significant in women (HR = 1.64, 95% CI 1.04 to 2.58), but not in men. 
Individuals who smoked and who were diagnosed with diabetes mellitus, hypertension or 
renal insufficiency were more likely to quit smoking than those without these conditions. 
On average, American Indians smoke fewer cigarettes per day than other racial/ethnic 
groups; nevertheless, the ill effects of habitual tobacco use are evident in this population. 
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1. Introduction 
Tobacco has a long and complicated history for American Indians, having been used for religious 
and therapeutic purposes early on and then later cultivated and traded with European settlers [1]. It is 
still used today in cultural practices, such as burial offerings, for spiritual protection, or as a gift [1]. 
Partly due to this history, a mystique surrounding tobacco and American Indians has evolved over 
time. American Indians have high rates of habitual tobacco use, particularly smoking, although 
chewing and dipping are also practiced. Smoking rates among adult American Indians are the highest 
for any race/ethnicity in the United States. In 1999–2001, 40.4% of American Indians aged 18 years 
and above reported cigarette use during the preceding month compared to the national average of 
26.5% [2–4]. In recent times the establishment of smoke shops which function as a source of 
livelihood in some Indian communities has also promoted this habit. Relatively little has been reported 
on the cardiovascular health effects of tobacco use among American Indians. 
Cardiovascular disease (CVD) risk factors have been studied extensively in longitudinal studies, 
including the Framingham Heart Study, studies from the Pooling Project, Multiple Risk Factor 
Intervention Trial (MRFIT), Atherosclerosis Risk in Communities (ARIC), and internationally in the 
World Health Organization (WHO) sponsored MONICA Study (Monitoring Trends and Determinants 
in Cardiovascular Diseases) [5–12]. These studies and others with prospective designs have confirmed 
that an elevated cholesterol level, high blood pressure and cigarette smoking are major risk factors for 
coronary heart disease (CHD), and high blood pressure and smoking are risk factors for all categories 
of stroke [13,14]. These studies provide interesting comparisons to the Strong Heart Study, a 
prospective study of CVD in American Indians. American Indians share the same risk factors as other 
populations, but have an increased susceptibility to and high prevalence of another important CVD risk 
factor—type 2 diabetes. In addition to the high rates of diabetes found among American Indians, there 
are also very high rates of tobacco use among some tribes [15–17]. When looking at multiple CVD risk 
factors simultaneously, Strong Heart Study investigations found smoking to be a risk factor for some 
subcategories of CVD but not others [18–21]. Tobacco use was not a focus of any of these studies. The 
present study focuses on tobacco use and its role as a contributor to CVD among participants in the 
Strong Heart Study.  
2. Experimental Section 
2.1. Study Population 
The Strong Heart Study is a prospective study of cardiovascular risk factors, and CVD morbidity 
and mortality among 13 American Indian tribes/communities residing in Arizona, Oklahoma and 
North and South (N/S) Dakota. The Strong Heart Study protocol was reviewed and approved by the 
institutional review boards (IRBs) of the participating institutions, the 13 participating tribes, and the 
Indian Health Service IRBs for the three geographic areas wherein the tribes reside. Each participant Int. J. Environ. Res. Public Health 2010, 7          
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gave informed consent. The initial cohort of 4,549 (2,703 females and 1,846 males) participants were 
aged 45 to 74 at first examination. Roughly 1,500 individuals were included from each center, among 
whom 4,293 were free from CVD and had known tobacco exposure status at the baseline examination. 
Baseline assessment was conducted between July 1989 and January 1992 with follow-up examinations 
at regular intervals. Each participant has been tracked for health outcomes, especially non-fatal and 
fatal CVD. The study design, method and participation rates have been explained in earlier Strong 
Heart Study publications [22,23].  
2.2. Risk Factor Assessments and Definitions 
The baseline examination consisted of a personal interview and a physical examination. Interview 
questions during this examination included information on demographics, family history, health habits, 
medical history and medications. After a five-minute rest, blood pressure was taken three times, and 
the mean of the last two measurements was used to estimate blood pressure. Anthropometric 
measurements of height and weight were taken, and body mass index (BMI) calculated as weight (kg) 
divided by height squared (m
2). A morning urine specimen was obtained for measurements of albumin 
and creatinine. After a 12-hour overnight fast, blood samples were obtained for laboratory 
measurements. A 75 gram oral glucose tolerance test was also performed [24]. 
Use of smoked tobacco was categorized. A current smoker was defined as a person who smoked 
more than 100 cigarettes in his/her lifetime and was still smoking. An ever smoker was defined as a 
person who smoked more than 100 cigarettes in his/her lifetime but was no longer smoking. A   
non-smoker was defined as a person who had not smoked more than 100 cigarettes in his/her lifetime 
and was not currently smoking. Diabetes mellitus was classified according to the American Diabetes 
Association (ADA) criteria, with diabetes defined as taking insulin or oral anti-diabetic medication or 
having a fasting glucose concentration ≥126 mg/dL. A person was considered to have hypertension if 
he/she had a systolic blood pressure ≥140 mmHg or a diastolic blood pressure ≥90 mmHg, or if he/she 
was taking antihypertensive medication. Renal problems were assessed by the ratio of albumin to 
creatinine in the urine. Microalbuminuria and macroalbuminuria were defined as a ratio of albumin to 
creatinine of 30–299 mg/g and ≥300 mg/g, respectively. 
2.3. Outcome Variables 
After the baseline assessment, reexaminations were conducted in 1993–1995 and 1998–1999. 
During each examination, a 12-lead ECG and medical history, including the Rose questionnaire for 
angina pectoris, were obtained [25]. Deaths of study participants were identified through obituaries in 
local newspapers, tribal and Indian Health Service hospital records and by direct contact of study 
personnel with the participant’s family or other informant. Cause of death was assessed through death 
certificates, autopsy reports, medical records and informant interviews, as reported previously [26]. 
Nonfatal CVD included definite myocardial infarction (MI), definite CHD and definite stroke. Fatal 
CVD included definite fatal MI, definite sudden death due to CHD, definite fatal CHD and possible 
fatal CHD, definite fatal stroke and possible fatal stroke. Events occurring till December 31, 2005 were 
included in the analysis. Mortality follow-up was 99.8% complete. Int. J. Environ. Res. Public Health 2010, 7          
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2.4. Statistical Methods 
Descriptive statistics (means, standard deviations and proportions) stratified by smoking status were 
calculated for men and women separately. Cox proportional hazards models with competing risks were 
employed to estimate the independent contribution of current smoking and ever smoking in men and 
women separately with time to first non-fatal and fatal CVD outcome [27]. Each proportional hazards 
model included relevant risk factors to control for possible confounding. SAS 9.1 (Cary, NC) was used 
for analysis.  
3. Results 
Variation is seen in the smoking rates among American Indians at the Strong Heart Study sites as 
seen in Figures 1 and 2. The prevalence of current smoking among the Oklahoma American Indian 
population was higher than that of Arizona American Indians, but less than that of the N/S Dakota 
American Indians. These rates were statistically different among the study sites for both males and 
females (P  ≤ 0.01). This exemplifies the variation seen regionally in the U.S. among   
American Indians. 
Prevalence of smoking was significantly higher among males than females with roughly 40% 
reporting current smoking. The Arizona site had the lowest smoking prevalence with only about one in 
five reporting current smoking, and 43.8% reporting no smoking. The Dakota site had the highest 
prevalence of smoking with roughly one-half of the participants reporting current and 22.7% reporting 
no smoking. The Oklahoma site had an intermediate prevalence proportion with roughly one-third 
reporting current and one-third no smoking. Also, smoking cessation rates were highest in Arizona and 
lowest in the Dakotas.  
The mean number of cigarettes smoked per day among current users was less in Arizona and higher 
in N/S Dakota as compared to Oklahoma. Figure 3 provides the mean numbers of cigarettes smoked 
per day at each site [22]. Even in N/S Dakota, the average for men was less than 20 cigarettes per day. 
At each center, women on average smoked fewer cigarettes per day than men. As might be expected, 
exposure to environmental tobacco smoke followed a similar pattern with greater exposure in N/S 
Dakota, less exposure in Oklahoma and the least exposure to environmental tobacco smoke in Arizona 
(Figure 4) [22].  
Baseline characteristics of participants stratified by smoking status are shown in Table 1. About 
one-third of the cohort was current smokers, one-third was ever-smokers and one-third was   
non-smokers. Covariates were not evenly distributed among the three smoking classifications   
(Table 1). Mean age was lowest among current smokers both male (54.7 years) and female   
(54.9 years). Body mass index (BMI [wt(kg)/ht(m)
2]) was lowest for current smokers of both genders, 
i.e., mean male BMI = 28.6 and mean female BMI = 30. The means of ever and never smokers were 
similar, 30.8 and 30.6 for ever and never male smokers respectively and 32.7 and 31.9 for ever and 
never female smokers respectively. The mean low density lipoprotein (LDL) cholesterol level was 
higher for current smokers compared to non-smokers for women and men though the differences were 
not statistically significant for men.  Int. J. Environ. Res. Public Health 2010, 7          
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For women only 36% of current smokers had diabetes compared to over 50% of ever and   
never smokers. The same pattern was seen in men with 33% of current smokers having diabetes, and 
47% of ever smokers and 44% of never smokers with diabetes. Hypertension was less common in both 
males and females who were current smokers. Current smoking status is statistically significantly 
associated with less diabetes mellitus, less hypertension, less albuminuria, younger age, lower BMI, 
lower HDL cholesterol and higher LDL cholesterol. 
Tables 2 and 3 provide hazard ratios for non-fatal and fatal CVD for ever smokers and current 
smokers compared to non-smokers after adjusting for other known risk factors. Compared with   
non-smokers, being a current smoker significantly increased the risk of non-fatal CVD by 94% in 
women after adjusting for age, BMI, LDL cholesterol, HDL cholesterol, quartile of physical activity, 
presence of hypertension, diabetes and macro and microalbuminuria (Table 2). Compared with   
non-smokers, being a current smoker significantly increased the risk of fatal CVD by 64% for women 
(Table 3). For men, compared  to non-smokers, neither being an ever nor current smoker reached 
statistical significance in the adjusted hazard ratios for fatal CVD. However, compared to male   
non-smokers, being a current smoker significantly increased the risk for non-fatal CVD by 59%.  
Table 4 displays the disease status stratified percentages of participants without CVD who quit 
smoking before the Phase 2 exam and remained free of CVD at the end of 2005. Participants with 
diabetes mellitus, hypertension or macro/microalbuminuria detected at the Phase 1 exam were 
significantly more likely to quit smoking than those without these conditions. 
Figure 1. Cigarette smoking among American Indian men by center, Strong Heart Study, 
1989–1992. Current smoker was defined as a person who smoked more than 100 cigarettes 
during his/her lifetime and answered ‘yes’ to the question “Do you smoke now?” An ever 
smoker was defined as a person who smoked more than 100 cigarettes in his/her lifetime 
but was not smoking now. A non-smoker was defined as a person who had not smoked 
more than 100 cigarettes in his/her lifetime and was not currently smoking. 
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Figure 2. Cigarette smoking among American Indian women by center, Strong Heart 
Study, 1989–1992. Current smoker was defined as a person who smoked more than   
100 cigarettes during his/her lifetime and answered ‘yes’ to the question “Do you smoke 
now?” An ever smoker was defined as a person who smoked more than 100 cigarettes in 
his/her lifetime but was not smoking now. A non-smoker was defined as a person who had 
not smoked more than 100 cigarettes in his/her lifetime and was not currently smoking. 
 
Figure 3. Number of cigarettes smoked per day among current smokers by center, Strong 
Heart Study, 1989–1992. Current smoker was defined as a person who smoked more than 
100 cigarettes during his/her lifetime and answered ‘yes’ to the question “Do you   
smoke now?”. 
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Figure 4. Mean number of hours per day of exposure to environmental tobacco smoke. 
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Table 1. Baseline characteristics by gender and smoking status, Strong Heart Study, 1989–1992. 
Variable 
 
Mean (S.D.)  
or % 
 
Males (n = 1689)  Females (n = 2604) 
Never 
(n = 308) 
(18%) 
Ever 
(n = 682) 
(40%) 
Current 
(n = 699) 
(41%) 
P-value 
Never 
(n = 1093) 
(42%) 
Ever 
(n = 738) 
(28.6%) 
Current 
(n = 773) 
(30%) 
P-value 
Age (years) 
 
55.7 
(7.8) 
55.9 
(7.9) 
54.7 
(7.4) 
0.016 57.6  (7.9)  56.5 
(7.9) 
54.9 
(7.5) 
<0.001 
BMI* 
 
30.6 
(6.4) 
30.8 
(6.1) 
28.6 
(5.3) 
<0.001 31.9  (6.7)  32.7 
(6.3) 
30.0 
(6.3) 
<0.001 
LDL cholesterol* 
(mg/dl) 
117.0 
(32.0) 
118.7 
(34.3)  
120.6 
(31.4) 
0.240 115.5 
(32.1)  
116.8 
(32.0) 
121.9 
(33.9) 
<0.001 
HDL cholesterol* 
(mg/dl) 
44.0 
(13.8) 
42.3 
(12.2) 
43.8 
(14.9) 
0.060 48.4 
(13.1) 
47.9 
(12.9) 
46.8 
(13.1) 
0.047 
Diabetes Mellitus* 
(%) 
44 47  33  <0.001  52 53 36  <0.001 
Hypertension* (%)  43  46  30  <0.001  42  41  28  <0.001 
Albumin/creatinine  
ratio 30–299 mg/g 
(%) 
18   18   17   0.762  21   22   15   <0.001 
Albumin/creatinine 
ratio ≥ 300 mg/g (%) 
12   11   6  0.002  12  14  8   <0.001 
Physical Activity 
(minutes in past 
week) 
87.7 
(96.7) 
91.6 
(101.1) 
99.6 
(100.5) 
0.150 49.6 
(63.0) 
60.4 
(71.9) 
69.6 
(73.7) 
<0.001 
* BMI, body mass index [weight (kg)/height (m)
2]; LDL cholesterol, low density lipoprotein 
cholesterol; HDL cholesterol, high density lipoprotein cholesterol; diabetes mellitus defined as 
taking insulin or oral anti-diabetic medication or having a fasting glucose concentration   
≥126 mg/dL; hypertension defined as having a systolic blood pressure ≥140 mmHg or a diastolic 
blood pressure ≥90 mmHg or taking antihypertensive medication.  Int. J. Environ. Res. Public Health 2010, 7          
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Table 2. Hazard ratios of risk factors related to non-fatal cardiovascular disease in 
American Indian men and women, Strong Heart Study, 1989–2005. 
  Males (n = 1,689)  Females (n = 2,604) 
Risk Factor  Hazard Ratio*  95% CI  Hazard Ratio  95% CI 
Current smoker†  1.59  1.16 2.18  1.94  1.54 2.45 
Ever smoker†  1.11  0.81  1.52  1.23  0.97  1.57 
Age  1.05  1.03 1.06  1.03  1.02 1.04 
BMI† 1.00  0.98  1.02  1.00  0.98  1.02 
LDL cholesterol†  1.01  1.01 1.01  1.01  1.00 1.01 
HDL cholesterol†  0.99  0.98  1.00  0.99  0.98  0.99 
2nd Quartile physical 
activity† 1.10  0.81  1.48  0.88  0.67  1.15 
3rd Quartile of 
physical activity†  0.91  0.67  1.24  1.01  0.77  1.31 
4th Quartile of 
physical activity†  1.08  0.81  1.45  0.87  0.66  1.15 
Diabetes mellitus†  1.61  1.27 2.05  2.35  1.87 2.97 
Hypertension†  1.36  1.10 1.69  1.33  1.08 1.64 
Macroalbuminuria†  1.82  1.28 2.58  2.25  1.70 2.97 
Microalbuminuria† 1.28  0.97  1.69  1.45  1.14 1.85 
* Cox proportional hazards models with competing risks were used to estimate the independent 
contribution of current smoking and ever smoking to non-fatal cardiovascular outcome. Bolded 
ratios were statistically significant (p ≤ 0.05). 
† Current smoker was defined as smoking at least 100 cigarettes during his/her lifetime and 
answering “yes” to the question, “Do you smoke now?; ever smoker was defined as smoking more 
than 100 cigarettes in his/her lifetime but not currently smoking; BMI, body mass index [weight 
(kg)/height (m)
2]; LDL cholesterol, low density lipoprotein cholesterol; HDL cholesterol, high 
density lipoprotein cholesterol; physical activity (minutes in past week) was calculated from all 
leisure-time exercise and activities by a questionnaire designed and validated for this study; 
diabetes mellitus was defined as taking insulin or oral anti-diabetic medication or having a fasting 
glucose concentration ≥126 mg/dl; hypertension was defined as having a systolic blood pressure 
≥140 mmHg or a diastolic blood pressure ≥90 mmHg or taking antihypertensive medication; 
macroalbuminuria was defined as a ratio of albumin to creatinine of ≥300 mg/g; and 
microalbuminuria was defined as a ratio of albumin to creatinine of 30–299 mg/g. Int. J. Environ. Res. Public Health 2010, 7          
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Table 3. Hazard ratios of risk factors related to fatal cardiovascular disease in American 
Indian men and women, Strong Heart Study, 1989–2005. 
Males (n = 1,689)  Females (n = 2,604) 
Risk Factor  Hazard Ratio*  95% CI  Hazard Ratio  95% CI 
Current smoker†  1.02  0.64  1.64  1.64  1.04 2.58 
Ever smoker†  0.61  0.38  0.99  1.33  0.88  2.02 
Age  1.08  1.05 1.10  1.07  1.04 1.09 
BMI† 1.00  0.96  1.03  0.96  0.93  0.99 
LDL cholesterol†  1.00  1.00 1.01  1.00  1.00 1.01 
HDL cholesterol†  1.01  0.99  1.02  0.99  0.97  1.00 
2nd Quartile 
physical activity†  1.10  0.68  1.80  0.67  0.43  1.04 
3rd Quartile of 
physical activity†  0.91  0.55  1.50  0.49  0.30  0.79 
4th Quartile of 
physical activity†  0.65  0.38  1.13  0.39  0.23  0.68 
Diabetes mellitus†  2.12  1.39 3.24  2.71  1.67 4.37 
Hypertension†  1.65  1.13 2.41  1.79  1.20 2.67 
Macroalbuminuria†  2.74  1.60 4.67  4.60  2.88 7.34 
Microalbuminuria† 1.52  0.96  2.41  1.76  1.09 2.84 
* Cox proportional hazards models with competing risks were used to estimate the independent 
contribution of current smoking and ever smoking to fatal cardiovascular outcome. Bolded ratios 
were statistically significant (p ≤ 0.05). 
† Current smoker was defined as smoking at least 100 cigarettes during his/her lifetime and 
answering “yes” to the question, “Do you smoke now?; ever smoker was defined as smoking more 
than 100 cigarettes in his/her lifetime but not currently smoking; BMI, body mass index [weight 
(kg)/height (m)
2]; LDL cholesterol, low density lipoprotein cholesterol; HDL cholesterol, high 
density lipoprotein cholesterol; physical activity (minutes in past week) was calculated from all 
leisure-time exercise and activities by a questionnaire designed and validated for this study; 
diabetes mellitus was defined as taking insulin or oral anti-diabetic medication or having a fasting 
glucose concentration ≥126 mg/dl; hypertension was defined as having a systolic blood pressure 
≥140 mmHg or a diastolic blood pressure ≥90 mmHg or taking antihypertensive medication; 
macroalbuminuria was defined as a ratio of albumin to creatinine of ≥300 mg/g; and 
microalbuminuria was defined as a ratio of albumin to creatinine of 30–299 mg/g.  Int. J. Environ. Res. Public Health 2010, 7          
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Table 4. Smoking cessation rates for current smokers according to disease status and 
smoking status at Phase 1 exam who did not have CVD at the end of 2005, Strong Heart 
Study, 1989–2005. 
Disease*  Smoking Cessation Rate 
(%)** 
p-value† 
Diabetes Mellitus*   
0.0012   Yes  23.48 
 No  15.40 
Hypertension*   
0.0139   Yes  22.78 
 No  16.43 
Renal Insufficiency*   
0.0006   Yes  26.34 
 No  16.22 
* Current smoker was defined as smoking at least 100 cigarettes during his/her lifetime and 
answering “yes” to the question, “Do you smoke now?; ever smoker was defined as smoking more 
than 100 cigarettes in his/her lifetime but not currently smoking; BMI, body mass index [weight 
(kg)/height (m)
2]; LDL cholesterol, low density lipoprotein cholesterol; HDL cholesterol, high 
density lipoprotein cholesterol; physical activity (minutes in past week) was calculated from all 
leisure-time exercise and activities by a questionnaire designed and validated for this study; 
diabetes mellitus was defined as taking insulin or oral anti-diabetic medication or having a fasting 
glucose concentration ≥ 126 mg/dl; hypertension was defined as having a systolic blood pressure 
≥140 mmHg or a diastolic blood pressure ≥90 mmHg or taking antihypertensive medication; 
macroalbuminuria was defined as a ratio of albumin to creatinine of ≥300 mg/g; and 
microalbuminuria was defined as a ratio of albumin to creatinine of 30–299 mg/g. Diseases were 
detected at Phase 1 exam. 
**Percentage of participants who quit smoking before Phase 2 exam. 
†p-value from testing rate differences between diseased and non-diseased. 
4. Discussion and Conclusions 
There has been a downward trend in tobacco use among American Indians with the smoking 
proportion dropping by 10% between 1987–1990 and 1994–1995 [2]. Use has continued to decline in 
the first decade of 2000 [28–30]. These trends should beneficially contribute to the health status of 
American Indians. Despite these trends, previous studies of selected American Indian tribes have 
found that smoking is not perceived as a risk factor for CVD [31,32]. 
Tobacco use is a major contributor to disease and death [33–35]. Among the 361,662 men screened 
for the MRFIT, cigarette smoking was an important risk factor for all-cause, CHD, stroke and cancer 
mortality [36]. Based on the Framingham Heart Study, Mamun et al. reported that male and female 
non-smokers live 8.66 and 7.59 years longer than smokers and have more years free of CVD [37]. 
There is little argument that tobacco use is a habit with considerable health risks attached. 
Among American Indians higher smoking rates were seen in younger individuals. In addition, 
smoking rates decreased with advancing age, and the mean age of current smokers was less than that of 
non-smokers [4]. As individuals aged and developed other CVD risk factors, they were more likely to Int. J. Environ. Res. Public Health 2010, 7          
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quit smoking. This has been reported by Zhang et al. [38] as well. Even though current smoking was 
associated with a reduced presence of other CVD risk factors, both male and female smokers had 
higher LDL cholesterol levels. An autopsy study has shown that smoking is associated with fatty 
streaks and raised lesions in the intimal surfaces of arteries in youth, providing further evidence for the 
contribution of smoking to atherogenesis [39].  
In a number of studies, current smoking increased the risk for CHD by 50% to 80%, and the risk 
appeared to be more evident in women than in men [40]. In the Strong Heart Study, American Indian 
women showed the adverse effects of smoking on CVD risk more noticeably than men. Despite the 
high prevalence of tobacco use, American Indians smoke fewer cigarettes each day compared to 
whites, and this may partly attenuate its impact on risk [2,4,28]. Based on the MRFIT, there was a 
graded risk of vascular disease with greater use associated with a greater CVD death rate in white  
men [41]. On the other hand, the Copenhagen City Heart Study of 12,149 men and women showed that 
smoking as little as 3–5 grams of tobacco per day (equivalent to 3–5 cigarettes per day) or not inhaling 
the smoke increased the risk of MI and all-cause mortality with a higher relative risk (RR) in women 
(RR = 2.14) than in men (RR = 1.86). In men, increased risks were seen when using 6–9 grams per day 
(equivalent to 6–9 cigarettes per day) with RRs of MI and all-cause mortality of 2.10 and 1.76 
respectively [42]. 
In the Strong Heart Study, smoking behavior differed based on risk factor stratification. Compared 
to ever smokers, both male and female current smokers had a lower prevalence of diabetes, 
hypertension, and albumin/creatinine ratio >300 mg/g(%). Greater proportions of those who smoked 
and had diabetes, hypertension or renal insufficiency quit smoking than those who smoked and did not 
have co-morbid conditions. The risk factors of diabetes, hypertension and albuminuria were 
statistically significant for both men and women and for both non-fatal and fatal CVD (HRs ranging 
from 1.33 to 4.60). It has been demonstrated that one or more major risk factors—an elevated 
cholesterol level, hypertension, cigarette smoking, or diabetes—are antecedent risks in over 85% of 
CHD events, and efforts to minimize these risk factors should be continued in all populations [43].  
The cultural and economic role of tobacco in American Indian communities complicates but does 
not prohibit prevention efforts. For thousands of years tobacco has played an integral role in some 
American Indian traditions. The problem is with abuse of tobacco and not with ceremonial or 
traditional use. There are participants in both the Strong Heart Study and Cherokee Diabetes Study 
who reported being non-smokers but who did use tobacco for ceremonial or sacramental purposes [4]. 
Loss of revenue from smoke shops in impoverished communities may bring an economic hardship  
to some; nevertheless, progress is being made in health literacy. Many tribal council meetings, once 
conducted in smoke filled rooms, are now smoke free [1]. Prevention and cessation programs are 
available though Indian Health Service programs and tribal health services, though more are needed in 
these communities.  
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